Butterfly iQ3 [Image courtesy of Butterfly Network]
Burlington, Massachusetts–based Butterfly began the U.S. rollout for its iQ3 third-generation handheld ultrasound device in February. The company powers the iQ3 with its most advanced semiconductor chip, featuring a data transfer rate that doubles its predecessor’s. This results in enhanced image quality and faster micro-beamforming for advanced 3D capabilities called iQ Slice and iQFan.
The semiconductor-based, single-probe, whole-body-ultrasound-offering iQ3 features a brand-new ergonomic design and provides double the data processing speed compared to previous generations.
Butterfly Network’s technology was named among the nominees for the award last month. Other technologies from some of the biggest names in medtech were also nominated. (See the full list of nominees HERE.)
The Galien Foundation aims to foster and reward achievements in improving the global human condition. According to a news release, the Prix Galien Awards are regarded as the “Nobel Prize of Life Sciences,” and the highest accolade for healthcare R&D.
“Winning the Prix Galien Award for Best Medical Technology is an extraordinary testament to the hard work and dedication of our team that brought iQ3 to market this year,” said Joseph DeVivo, President, Chief Executive Officer, and Board Chairman of Butterfly Network. “Our Ultrasound-on-Chip™ technology harnesses the exponential advancements of Moore’s Law, allowing us to deliver increasingly powerful and cost-effective imaging tools. By leveraging this innovation, we are democratizing ultrasound, enabling practitioners everywhere to make faster, more accurate decisions, and ultimately transforming patient care on a global scale.”
